FDA ANDA · ANDA073632

METAPROTERENOL SULFATE

Sponsor: CHARTWELL

APPLICATION

ANDA073632

TYPE

ANDA

ORIGINAL APPROVAL

1992-07-22

LATEST ACTION

2001-07-11

ROUTE

ORAL

DOSAGE FORM

SYRUP

MARKETING STATUS

Prescription

Products

METAPROTERENOL SULFATEPrescription

METAPROTERENOL SULFATE 10MG/5ML · SYRUP · ORAL

2001-07-11Manufacturing (CMC) · Supplement 9AP

1999-03-01Manufacturing (CMC) · Supplement 8AP

1999-03-01Manufacturing (CMC) · Supplement 7AP

1994-12-06Manufacturing (CMC) · Supplement 6AP

1994-12-06Manufacturing (CMC) · Supplement 4AP

1994-12-06Manufacturing (CMC) · Supplement 5AP

1993-05-28Manufacturing (CMC) · Supplement 2AP

1993-03-01Manufacturing (CMC) · Supplement 3AP

1992-07-22OriginalAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.